From Innovative Therapies to Real-World Research: International Experts Gather in Boao Lecheng, China, to Shape Future of Medicine

Core Insights - The 1 Global Innovative Pharmaceutical and Medical Device Expo and the 4 International Conference on Real-World Studies of Medical Products were recently held in Boao Lecheng, showcasing over 100 types of cutting-edge international pharmaceuticals and medical devices, attracting around 1,000 professionals from various sectors [1][2] Group 1: Event Overview - The expo featured discussions on the latest developments in international medicine, with participation from professionals across multiple countries including China, Spain, Australia, and Italy [2] - The pilot zone in Lecheng is China's only "medical special zone," which has attracted over 30 medical institutions and introduced more than 520 advanced pharmaceuticals and medical devices, benefiting over 200,000 patients [4] Group 2: Innovations and Technologies - The expo highlighted over 100 international innovations, including novel therapies for small cell lung cancer and the world's first intelligent cochlear implant system, showcasing advancements in oncology, AI-assisted diagnosis, and cell therapy [7] - Top medical experts discussed breakthroughs in global innovative therapies for rare diseases and the integration of AI technology in medical treatments [5] Group 3: Regulatory and Market Impact - Lecheng is positioned as a global hub for innovative medical products, having accelerated the approval of 21 international innovative drugs and medical devices in China and supported the inclusion of three products in the national medical insurance catalog [8] - The International Conference on Real-World Studies of Medical Products included discussions with organizations like WHO and the U.S. FDA on accelerating the adoption of international medical products in China [9] Group 4: Future Prospects - Lecheng is rapidly developing into a world-class destination for international medical tourism and a leading platform for medical technology innovation, with expectations of accelerated development once the Hainan Free Trade Port becomes fully operational [11]